SiNtx Technologies Inc (SINT)

[farmer6]

Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations

Mar 19, 2018

WARSAW, Ind., March 19, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Coleman (Cole) N. Lannum has been appointed Senior Vice President of Investor Relations, reporting directly to the Company's President and CEO, Bryan C. Hanson.

ZIMMER BIOMET INC. LOGO (PRNewsFoto/Zimmer Holdings, Inc.)

Mr. Lannum joins Zimmer Biomet with more than 15 years of Investor Relations (IR) experience in the healthcare industry. Most recently, he served as Senior Vice President of Investor Strategy and Investor Relations Officer for Mallinckrodt Pharmaceuticals, where he consulted with executive management and the Board of Directors regarding the Company's acquisitions, strategic direction and shareholder value optimization.

Prior to joining Mallinckrodt in 2015, Mr. Lannum led IR at Covidien and Tyco Healthcare for nine years. As Vice President and Investor Relations Officer, he designed Covidien's IR program, oversaw the largest-ever healthcare Initial Public Offering and led the IR effort through the company's merger with Medtronic in 2015.